Navigation Links
The Strongly Growing Chinese Heart Valve Market Has A Number Of Distinct Features That Will Challenge Competitors
Date:9/5/2013

TORONTO, Sept. 5, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the Chinese heart valve market is underpenetrated and will grow rapidly in the next decade. But this particular market differs in significant ways from mature markets, and the differences need to be taken into account by competitors seeking to gain or maintain a market position in China.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO)

The heart valve market is showing strong procedure growth. MRG sees approximately 16,500 surgical heart valve procedures per quarter, but anticipates acceleration in the second half of the year, leading to an annual total of 70,000 procedures. By comparison, the number in the United States was just over 100,000 in 2012, for a population under one quarter China's.

The Chinese market still favors mechanical heart valves, which are relatively less frequent in mature markets. A still-high incidence of rheumatic fever causes valve damage early in life, particularly to the mitral valve. Mechanical heart valves, despite drawbacks such as higher cost and more complicated procedures, are favored for situations where durability is a key consideration. Despite the growth in the number of older patients, for whom tissue heart valves are a better choice, MRG expects mechanical valves to remain the largest segment for the next five years. In China, 61 percent of all heart valves are mechanical, while in the US mechanical valves represent only 21 percent of the surgical valve market.

"Another significant difference between procedures in China as opposed to mature markets is valve position," said MRG Project Analyst Thomas Lee. "While 70 percent of procedures are for the aortic valve in the US, in China that number is only 40 percent. The high rates of mitral valve damage make those procedures considerably more common in China than elsewhere."

The Chinese heart valve market has still not seen China Food and Drug Administration (CFDA) approval for minimally invasive transcatheter aortic valves (TAVR or TAVI), which is seeing major uptake in mature markets. But it is anticipated that Edwards will gain approval for its Sapien XT valve later this year. If results are similar to those in other markets, the device will be used initially to grow the treatable patient population, but will eventually erode some of the surgical heart valve market. .

These results can be found in a new tracking study from MRG:  China Heart Valves Marketrack.  This study fields quarterly to 80 hospitals across 25 provinces, and tracks procedure growth, device market size, price per device and brand usage on a quarterly basis.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort
Decision Resources, Inc.
781-993-2597
ccomfort@dresources.com

Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NEW POLL: Tennessee Voters Strongly Oppose Making Popular Cold and Allergy Meds Prescription Only
2. US Orthopedic Biomaterial Market to Grow Strongly to $3.7 Billion by 2017
3. US Peripheral Vascular Device Market to Grow Strongly to $3.3 Billion by 2017
4. XYMOGEN Named Among The Nations Fastest Growing Private Companies For The Sixth Time
5. Competitive Activity In The Electrophysiology Mapping And Ablation Device Market Will Be Fueled By The Growing Focus On Atrial Fibrillation Treatment
6. PTS, Inc. Named to Inc. 500/5000 Fastest Growing Private Companies for Third Time
7. PRN Physician Recommended Nutriceuticals Selected for the Second Consecutive Year to the Inc. 500
8. 5000 List of Fastest-Growing Privately Held Companies
9. Cardinal Health Helps Retail Pharmacies Meet Growing Patient Demand For Convenient Access To Home Health Care Products
10. The Launch of Three New Parkinsons Disease Therapies Through 2015 Will Help Offset Market Losses Resulting from the Growing Impact of Generics
11. Growing Opportunities in the Construction, Pharma and E-learning Sectors in India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... -- Global Health Intelligence (GHI), the leading healthcare ... published its 2017 ranking of the Best-Equipped Hospitals in ... analysis from GHI,s hospitals database for Latin America , ... The GHI database covers 86% of the hospitals in ... points for each institution in key areas such as beds, ...
(Date:5/9/2017)... , May 9, 2017  Demonstrating its ... board of directors for the Pharmaceutical Research and ... for membership. Biopharmaceutical companies will now have to ... order to be eligible to join PhRMA. ... the board is sending a clear message that ...
(Date:5/6/2017)... Texas , May 5, 2017   Provista , ... with more than 200,000 customers, today announced Jim Cunniff ... a wealth of executive and business experience to Provista, including ... compounding pharmacy in California . He assumed ... "Jim is a great fit for Provista," says ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... May 26, 2017 , ... Amir Qureshi, MD is the first physician in ... cord stimulation system. The Nuvectra™ Algovita SCS System has been FDA approved as a ... first in Arkansas to introduce the most powerful SCS system and the only stretchable ...
(Date:5/26/2017)... Fla. (PRWEB) , ... May 26, 2017 , ... ... of premium delicatessen foods, is sharing bold recipes for Memorial Day entertaining that ... your menus. , “Boar’s Head fresh sliced meats and cheeses featured in ...
(Date:5/26/2017)... ... 26, 2017 , ... After raising nearly $30,000 on Kickstarter , about ... available at a discounted crowdfunding price on Indiegogo . , “Along with creating ... wanted to bring a fidget toy to the market that was made of superior ...
(Date:5/26/2017)... ... May 26, 2017 , ... Rob Lowe acts as host and ... the series is on hiking in American. Viewers can reconnect with America as it ... of hiking. , Many consumers have looked for an inventive new place for a ...
(Date:5/26/2017)... ... ... Cross”: the personal journey of Bob Massey and his faith in the Lord. “THE ... Massey. Bob Massey is small in stature but big in character. As Johnny ... others is apparent in all of his life decisions. , “I’m in the eightieth ...
Breaking Medicine News(10 mins):